Theresa Pluth Yeo,Albert B Lowenfels
Theresa Pluth Yeo
Pancreatic cancer affects 44,000 Americans and at least 250,000 individuals worldwide annually. The incidence is slowly increasing after a recent period of decline. Cases are predicted to increase globally because of increased longevity and...
Charles J Yeo
Charles J Yeo
Lymphomatoid granulomatosis [0.03%]
淋巴样肉芽肿病
Mark Roschewski,Wyndham H Wilson
Mark Roschewski
Lymphomatoid granulomatosis (LYG) is a very rare Epstein-Barr virus (EBV)-driven lymphoproliferative disease. The atypical lymphoid cells directly accumulate within affected tissues and clinically present in the form of infiltrative lesions...
Joachim M Baehring,Tracy T Batchelor
Joachim M Baehring
Invasion of cranial nerves and peripheral nerve roots, plexus, or nerves by non-Hodgkin lymphoma is denoted as neurolymphomatosis (NL). Four clinical patterns are recognized. Most commonly, NL presents as a painful polyneuropathy or polyrad...
Nonmyeloablative allogeneic stem cell transplantation for non-hodgkin lymphoma [0.03%]
非清髓性异基因干细胞移植治疗非霍奇金淋巴瘤
Issa F Khouri,Richard E Champlin
Issa F Khouri
Non-Hodgkin lymphomas constitute a heterogeneous group of hematologic malignancies with varying aggressiveness and many therapeutic options. Nonmyeloablative (NMA) conditioning has been the cornerstone of allogeneic adoptive immunotherapy f...
Kelley V Foyil,Nancy L Bartlett
Kelley V Foyil
Systemic anaplastic large-cell lymphoma (ALCL) is a rare, mature T-cell non-Hodgkin lymphoma. Anaplastic large-cell lymphoma cells express the surface antigen CD30, and more than half express the anaplastic lymphoma kinase (ALK) protein. Th...
Should patients with aggressive peripheral T-cell lymphoma all be treated the same?: no... well yes, ...but maybe not for long [0.03%]
侵袭性外周T细胞淋巴瘤患者都采用相同的治疗方案吗?不一定……但或许不会太久……
Alison J Moskowitz,Matthew A Lunning,Steven M Horwitz
Alison J Moskowitz
The peripheral T-cell lymphomas represent about 15% to 20% of non-Hodgkin lymphomas and are marked by clinical and pathologic heterogeneity. The most common T-cell entities include peripheral T-cell lymphoma, not otherwise specified, angioi...
Management of the cutaneous peripheral T-cell lymphomas: when subtypes matter [0.03%]
皮肤周边T细胞淋巴瘤的治疗:分类的重要性
Michael Youngjun Choi,Mary Jo Lechowicz
Michael Youngjun Choi
The cutaneous T-cell lymphomas are a heterogeneous collection of many biologically and clinically distinct cancers. The World Health Organization 2008 reclassification of cutaneous lymphomas delineated provisional entities that were previou...
Craig A Portell,John W Sweetenham
Craig A Portell
Adult lymphoblastic lymphoma (LBL) is an aggressive form of non-Hodgkin lymphoma occurring in predominantly adolescent and young adult men. Lymphoblastic lymphoma is rare, accounting for 1% to 2% of all non-Hodgkin lymphomas and is of T-cel...
Julie M Vose
Julie M Vose
Mantle cell lymphoma (MCL) represents about 5% to 9% of all non-Hodgkin lymphomas according to the World Health Organization. The clinical presentation typically consists of diffuse lymphadenopathy and frequent extranodal involvement of the...